Liver News and Research

RSS

Researchers find a way to interfere with the energy pathway that promotes liver cancer spread

The World Health Organization projects that starting in 2030, over a million people will die each year from liver cancer.

4 Feb 2022

Fritz Lipmann Institute receives 2.5 million euros to advance microbiome research

Fungi, bacteria, archaea and viruses - trillions of microorganisms colonize the skin, mucous membranes and organs of humans. Together, they constitute the microbiome.

3 Feb 2022

Experimental immunotherapy could help treat some people with metastatic breast cancer

An experimental form of immunotherapy that uses an individual's own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer, according to results from an ongoing clinical trial led by researchers at the National Cancer Institute's Center for Cancer Research, part of the National Institutes of Health.

1 Feb 2022

Liver hormone suppresses alcohol consumption in primates, study shows

A hormone produced by the liver called fibroblast growth factor 21 (FGF21) suppresses alcohol consumption in primates, finds a study published February 1 in the journal Cell Metabolism.

1 Feb 2022

Dexamethasone administration at a late time point could enhance transgene expression

Dexamethasone, a glucocorticoid with anti-inflammatory and immunosuppressive effects, can transiently increase the expression of therapeutic genes delivered using adeno-associated virus (AAV) vectors.

31 Jan 2022

New approach to make RNA vaccines easier to swallow

Like most vaccines, RNA vaccines have to be injected, which can be an obstacle for people who fear needles. Now, a team of MIT researchers has developed a way to deliver RNA in a capsule that can be swallowed, which they hope could help make people more receptive to them.

31 Jan 2022

Study reveals potential mechanism for iron accumulation in the aging brain

Breakdowns in regulatory mechanisms cause iron to build up in the brain as organisms grow older, increasing oxidative stress and causing cellular damage, according to a Northwestern Medicine study published in the journal eLife.

31 Jan 2022

Study assesses the antibody response to additional dose of COVID-19 vaccine in transplant recipients

A study has begun to assess the antibody response to an additional dose of a COVID-19 mRNA vaccine in kidney and liver transplant recipients, either alone or with a concurrent reduction in immunosuppressive medication.

31 Jan 2022

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Severe visual illnesses are increasing in our society, and effective treatments are missing for diseases as age-related macular degeneration, diabetic retinopathy, and glaucoma. Both industry and academia are highly interested to advance ocular drug discovery and development.

29 Jan 2022

Researchers develop new tool to determine patients' liver cancer risk after hepatitis C

Hepatitis C can now be effectively treated, thanks to modern drugs. However, despite having been cured, some patients can go on to develop liver cancer. Currently, biannual ultrasound screening is done to monitor for incipient cancer.

28 Jan 2022

Desipramine and L-cycloserine together reduce ceramide levels in the retina and enhance vision

Researchers from the University of California, Irvine have discovered that the absence of Adiponectin receptor 1 protein (AdipoR1), one of the principal enzymes regulating ceramide homeostasis in the retina, leads to an accumulation of ceramides in the retina, resulting in progressive photoreceptor cell death and ultimately vision loss.

28 Jan 2022

Two-step strategy can help determine the risk of liver cancer after HCV cure

The results of the study, conducted from the Virgen del Rocío Hospital, reveal the importance of personalized medicine and evaluating each patient.

27 Jan 2022

Blood proteoforms may help predict liver transplant rejection

Northwestern University scientists have discovered families of proteins in the body that could potentially predict which patients may reject a new organ transplant, helping inform decisions about care.

27 Jan 2022

Predicting pregnancy health and preeclampsia risk with blood RNA sequencing

In this interview, News-Medical speaks to Dr. Thomas McElrath about his latest research into a maternal-fetal medicine technique for predicting pregnancy health.

27 Jan 2022

UofL professor wins $6.7 million grant to investigate how metals cause lung cancer

For nearly three decades, John Pierce Wise Sr. has investigated the connection between exposure to metals and cancer, working both in the lab and in the field, reporting significant discoveries about the effects of metals on chromosomes in lung cancer and how those effects differ in humans and in whales.

27 Jan 2022

Study highlights the risk of kidney disease and obesity in people with type 1 diabetes

People with type 1 diabetes should be screened regularly for obesity and chronic kidney disease, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

27 Jan 2022

More than 5,000 people enrolled in PANORAMIC study for COVID-19 antivirals

Over 5,000 vulnerable people have now enrolled into a world-class study for the chance to receive life-saving antivirals, the government has announced today (Wednesday 26 January 2022).

26 Jan 2022

New therapeutic approach offers hope to treat obesity and related metabolic disorders

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new therapeutic approach to obesity and related metabolic disorders that in laboratory experiments demonstrated a significant reduction in body fat, body weight, and improvement in the blood markers that accompany these disorders.

25 Jan 2022

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Patients with alcohol-associated cirrhosis have poorer outcomes after ICU discharge, compared to patients with cirrhosis linked to other causes, according to new Mayo Clinic research.

25 Jan 2022

Lucky genes can help lower risk of diseases in people with obesity

Geneticists have revealed why some people with obesity remain relatively healthy, whilst others suffer from life-changing ailments such as type 2 diabetes and heart disease.

25 Jan 2022

Liver News and Research

Researchers find a way to interfere with the energy pathway that promotes liver cancer spread

Fritz Lipmann Institute receives 2.5 million euros to advance microbiome research

Experimental immunotherapy could help treat some people with metastatic breast cancer

Liver hormone suppresses alcohol consumption in primates, study shows

Dexamethasone administration at a late time point could enhance transgene expression

New approach to make RNA vaccines easier to swallow

Study reveals potential mechanism for iron accumulation in the aging brain

Study assesses the antibody response to additional dose of COVID-19 vaccine in transplant recipients

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Researchers develop new tool to determine patients' liver cancer risk after hepatitis C

Desipramine and L-cycloserine together reduce ceramide levels in the retina and enhance vision

Two-step strategy can help determine the risk of liver cancer after HCV cure

Blood proteoforms may help predict liver transplant rejection

Predicting pregnancy health and preeclampsia risk with blood RNA sequencing

UofL professor wins $6.7 million grant to investigate how metals cause lung cancer

Study highlights the risk of kidney disease and obesity in people with type 1 diabetes

More than 5,000 people enrolled in PANORAMIC study for COVID-19 antivirals

New therapeutic approach offers hope to treat obesity and related metabolic disorders

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Lucky genes can help lower risk of diseases in people with obesity

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News